30 April 2025 in Journal of Cardiovascular Electrophysiology
Background: It remains to be answered whether further enlargement of the isolation area in the left atrium (LA) could produce better effectiveness than pulmonary vein antrum isolation (PVAI) for treatment of atrial fibrillation (AF).Aims: To assess the effectiveness of superwide left atrial circumferential ablation (SWLACA) for treatment of persistent AF (PeAF) through a randomized controlled study.Methods: A total of 248 patients (male 63.7%, median age 65 years) with PeAF were randomly divided into the SWLACA group and PVAI group. The circumferential lines were located 2–3 cm from the PV ostia in the SWLACA group and approximately 1 cm in the PVAI group, respectively. The primary endpoint was the recurrence of atrial tachyarrhythmia after a single procedure.Results: Conduction block between LA and pulmonary veins (PVs) were achieved in all patients. The isolation areas were obviously larger in the SWLACA group (p < 0.001). Compared with the PVAI group, the SWLACA group was associated with a longer procedure duration (p = 0.013) and fluoroscopic time (p = 0.038). During the 12‐month follow‐up, the overall recurrence rate of atrial tachyarrhythmia after a single procedure was not significantly different between the two groups (21.0% vs 26.6%; p = 0.297). However, the SWLACA group had significantly fewer AF recurrences (12.9% vs. 25.0%; p = 0.015), and more atrial tachycardia recurrences (8.1% vs. 1.6%; p = 0.018). After multiple procedures, the SWLACA group had a significantly higher total arrhythmia recurrence‐free rate (p = 0.030).Conclusions: Compared with PVAI, although SWLACA did not significantly decrease the overall arrhythmia recurrence rate for PeAF, it was associated with a notable reduction in the recurrence of AF.
29 October 2025 in Reviews in Cardiovascular Medicine
Background: Atrial fibrillation catheter ablation (AFCA) success rates vary across different phenotypes of hypertrophic cardiomyopathy (HCM). Therefore, we compared long-term outcomes between apical (aHCM) and septal (sHCM) subtypes of HCM. Methods: This retrospective study analyzed patients with HCM who underwent AFCA at the First Affiliated Hospital of Nanjing Medical University between January 2010 and December 2020. Results: A total of 36 patients with aHCM and 80 patients with sHCM were enrolled. During a median follow-up of 42 months (interquartile range (IQR) 18–83), the overall atrial tachyarrhythmia (ATa) recurrence rate after a single ablation was 42.2% (49/116). The aHCM patients had a higher ATa recurrence rate than the sHCM patients (58.3% vs. 35.0%; χ2 = 5.54; p = 0.019). The ATa recurrence risk increased by 94% in patients with aHCM (hazard ratio (HR) 1.94, 95% confidence interval (CI) 1.10–3.43; log-rank p = 0.021). Subgroup analysis demonstrated pronounced risk elevation in paroxysmal atrial fibrillation (AF) patients (HR 2.85, 95% CI 1.44–5.67; p = 0.003), while no intergroup difference was observed in patients with persistent AF (HR 0.90, 95% CI 0.31–2.62; p = 0.853) (interaction p = 0.080). Multivariate Cox regression analysis identified antiarrhythmic drug (AAD) use (HR 0.22, 95% CI 0.08–0.59; p = 0.003), hypertension comorbidity (HR 2.50, 95% CI 1.21–5.19; p = 0.014), persistent AF type (HR 0.41, 95% CI 0.17–1.00; p = 0.049), and left atrial diameter ≥45 mm (HR 2.55, 95% CI 1.11–5.85; p = 0.028) as independent predictors of postoperative recurrence. Conclusions: An aHCM subtype predicts higher ATa recurrence after a single ablation versus sHCM. Hypertension, a left atrial enlargement ≥45 mm, and no AAD use are independent predictors of recurrence. Meanwhile, optimizing blood pressure and AAD therapy may improve outcomes.